Why Red Flags Matter
The rapid growth of ketamine prescribing — especially through telehealth — has created a spectrum of provider quality ranging from excellent to deeply concerning. Some providers are delivering rigorous, patient-centered care with appropriate safety protocols. Others are essentially medication mills: prescribing quickly, monitoring minimally, and prioritizing revenue over patient welfare.
Identifying red flags before committing to a provider protects you from substandard care, unnecessary risks, and the financial and time costs of restarting with a better provider after a bad experience. For a proactive approach, our list of 15 questions to ask a potential provider gives you concrete tools for evaluating quality.
Intake and Screening Red Flags
Minimal or No Clinical Evaluation
Red flag: The intake process consists primarily of online questionnaires with no live clinical conversation, or a video "consultation" of less than 20 to 25 minutes for a new psychiatric patient.
Why it matters: A thorough evaluation of psychiatric history, medical history, current medications, substance use, and cardiovascular status cannot be adequately accomplished in a brief questionnaire. Providers who skip this step are either uninformed about what adequate evaluation requires or are prioritizing speed over safety. Our article on what to tell your doctor describes what a thorough evaluation should cover.
Guaranteed or Near-Certain Approval
Red flag: Marketing language or intake staff communications that imply approval is essentially guaranteed if you complete the forms, or that the consultation is a formality before prescribing.
Why it matters: Legitimate ketamine prescribers turn patients away — because of contraindications, inadequate diagnosis documentation, concurrent medications, or clinical judgment that the patient is not appropriate. A provider who approves everyone has likely not evaluated anyone properly.
No Contraindication Discussion
Red flag: The provider does not ask about and discuss conditions that would preclude or modify ketamine prescribing (uncontrolled hypertension, psychosis, active mania, pregnancy, certain cardiovascular conditions, active substance use disorders).
Why it matters: Prescribing ketamine to a contraindicated patient can cause serious harm. A provider who doesn't evaluate for contraindications is not practicing safely.
No Medication Review
Red flag: The provider does not ask for or review a complete medication list, or does not discuss drug interactions involving your current medications.
Why it matters: Ketamine interacts with numerous drugs. Prescribing without a medication review exposes patients to potentially dangerous combinations.
Protocol and Monitoring Red Flags
No Monitoring Requirements
Red flag: The provider does not require any between-session monitoring — no blood pressure checks, no symptom tracking, no reporting of adverse effects.
Why it matters: Ketamine transiently elevates blood pressure and heart rate. For patients with any cardiovascular risk, monitoring identifies problems early. The absence of monitoring requirements signals either ignorance of risks or indifference to them.
No Follow-Up Structure
Red flag: After the initial prescription, the provider only reaches out when the patient initiates, or follow-up appointments are offered no more frequently than every 3 to 6 months.
Why it matters: Ketamine treatment requires ongoing dose management, monitoring of adverse effects, and assessment of treatment response. Quarterly follow-up is inadequate for most patients, particularly in the early treatment phase.
Willingness to Escalate Doses Rapidly Without Clinical Justification
Red flag: A provider who readily agrees to rapid dose escalation ("Sure, we can double your dose") without asking about response, adverse effects, or reviewing session logs.
Why it matters: Rapid dose escalation without clinical rationale can produce overwhelming sessions, cardiovascular stress, and potential dependence dynamics. Responsible prescribers escalate based on clinical evidence, not patient request alone.
Financial and Business Red Flags
High-Pressure Sales for Treatment Packages
Red flag: Initial contact involves being pushed to purchase packages of 6, 12, or 24 sessions upfront before any clinical evaluation, with financial pressure tactics or time-limited "discounts."
Why it matters: Treatment response is uncertain and individualized. Requiring large upfront financial commitments before evaluating whether treatment is appropriate puts financial interest ahead of clinical judgment.
Extremely Low Prices That Seem Too Good
Red flag: Prices that are dramatically lower than market rates without explanation (e.g., $50 per month for the full program when comparable programs cost $300).
Why it matters: Quality ketamine treatment has real costs: prescriber time, PCAB-accredited pharmacy medication, ongoing monitoring. Prices that seem impossibly low may reflect corners being cut on prescriber experience, pharmacy quality, or monitoring rigor.
Financial Conflicts With Pharmacy
Red flag: Provider who cannot explain their pharmacy recommendation or who becomes defensive when asked, combined with a pattern of exclusively directing all patients to one specific pharmacy.
Why it matters: Referral arrangements between providers and pharmacies exist and create incentives that may not align with patient interests. You should be able to ask why a pharmacy is recommended and receive a substantive clinical answer.
Clinical and Safety Red Flags
No Discussion of Integration Therapy
Red flag: The provider makes no mention of psychological integration support, does not ask whether you have a therapist, and provides no resources or recommendations for therapy alongside ketamine.
Why it matters: Ketamine therapy without integration is less effective and less safe for patients with significant trauma histories or complex psychiatric presentations. A provider who ignores this dimension is offering incomplete care.
Prescribing to Clearly Contraindicated Patients
Red flag: Prescribing ketamine to a patient with known uncontrolled psychosis, active mania, or uncontrolled severe hypertension — any of which are either absolute or strong relative contraindications.
Why it matters: This is a clinical safety failure that exposes the patient to serious harm. If you are aware that a provider prescribed ketamine to you or someone you know despite clear contraindications, consider reporting this to the state board of medicine or pharmacy.
No Discussion of Driving and Activity Restrictions
Red flag: Provider does not mention that patients should not drive or operate machinery for 4 to 6 hours after a session.
Why it matters: This is a basic safety requirement. A provider who doesn't discuss it may not have thought through post-session safety at all.
Emergency Protocol Absent
Red flag: No response when asked "What should I do if I have a medical emergency during a session?" — or a response that amounts to "just call 911" without additional provider-specific protocols.
Why it matters: The provider should have a clear emergency protocol: when to call 911, how to reach the provider after hours, what information to give emergency services about the medication, and any specific guidance for managing ketamine-related adverse events.
What to Do If You Identify Red Flags
If you identify red flags in your current provider relationship:
- Decide whether they are deal-breakers: A single concern might be addressable through conversation; multiple red flags suggest a pattern.
- Have a direct conversation: Raise specific concerns and evaluate the response.
- Seek a second opinion: Consult another qualified provider about their approach to your specific situation.
- Change providers if necessary: You can transfer your care. Request your medical records, obtain a copy of your prescription history, and find a provider whose practices meet appropriate standards.
- Report serious concerns: Providers who engage in clearly harmful or fraudulent practices can be reported to state medical boards and boards of pharmacy.
Key Takeaways
- Minimal intake evaluation, guaranteed approval, and no monitoring requirements are the most serious red flags.
- Financial red flags include high-pressure sales, suspiciously low prices, and opaque pharmacy relationships.
- A quality provider welcomes questions about protocols, monitoring, pharmacy quality, and emergency procedures.
- Identifying red flags early protects your safety and saves you from investing in substandard care.
- Changing providers is always an option; document your concerns and seek a better fit.
References
- StatPearls: Ketamine — Comprehensive clinical reference on ketamine pharmacology, mechanisms of action, and therapeutic applications
- PubChem: Ketamine Compound Summary — NCBI chemical database entry with ketamine molecular data, pharmacokinetics, and bioactivity profiles
- MedlinePlus: Ketamine — National Library of Medicine consumer drug information on ketamine including uses, proper administration, and precautions
- HHS: Telehealth — U.S. Department of Health and Human Services guide to telehealth services, regulations, and patient resources
- SAMHSA: National Helpline — Substance Abuse and Mental Health Services Administration free treatment referral and information service
Share